Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The study was an open label, balanced, randomized, two-treatment, two-period, two sequence,
single oral dose, crossover, bioequivalence study of two formulations of Valsartan 320 mg
under fed conditions.